Kashiv BioSciences signs an exclusive licensing and supply agreement with Intas Pharmaceuticals to commercialize a complex peptide product in Europe, the UK, and India.
Read MoreIntas Pharmaceuticals
Prothya Biosolutions Acquisition Marks Intas’s Global Expansion in Plasma-Derived Medicines
Prothya Biosolutions operates plasma collection centres across Hungary and employs approximately 1200 people, making it one of Europe’s largest plasma fractionators.
Read More